Royal Bank Of Canada Syndax Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 9,377 shares of SNDX stock, worth $149,563. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,377

Previous 8,215 14.14%

Holding current value

$149,563

Previous $168,000 7.14%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $20,834 - $28,829	1,162 Added 14.14%	9,377 $180,000
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $117,229 - $148,187	6,229 Added 313.65%	8,215 $168,000
Q1 2024 Nov 05, 2024	SELL	$19.71 - $24.57 $122,773 - $153,046	-6,229 Reduced 75.82%	1,986 $47,000
Q1 2024 May 15, 2024	SELL	$19.71 - $24.57 $342,480 - $426,928	-17,376 Reduced 89.74%	1,986 $47,000
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $89,787 - $170,824	7,883 Added 68.67%	19,362 $418,000
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $59,909 - $89,823	4,126 Added 56.11%	11,479 $166,000
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $23,258 - $26,816	1,202 Added 19.54%	7,353 $153,000
Q1 2023 May 15, 2023	SELL	$20.66 - $28.98 $68,735 - $96,416	-3,327 Reduced 35.1%	6,151 $129,000
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $120,867 - $153,661	5,856 Added 161.68%	9,478 $241,000
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $61,656 - $82,575	3,331 Added 1144.67%	3,622 $87,000
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $37,169 - $53,083	-2,725 Reduced 90.35%	291 $6,000
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $84,810 - $126,587	-5,715 Reduced 65.46%	3,016 $52,000
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $126,043 - $185,961	8,276 Added 1818.9%	8,731 $192,000
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $36,381 - $51,935	-2,623 Reduced 85.22%	455 $9,000
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $41,306 - $77,504	3,078 New	3,078 $53,000

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $902M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Syndax Pharmaceuticals Inc Transaction History